Solas BioVentures
Finance · Tennessee, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
835 Georgia Ave Ste 800, Chattanooga, Te...Phone Number
(423) 648-7894Website
www.solasbio.comRevenue
<$5 MillionIndustry
About Solas BioVentures
Solas BioVentures Org Chart
Partner
Partner
General Partner
Analyst
Advisor
Is Solas BioVentures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Solas BioVentures launches new products
Solas BioVentures, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Solas BioVentures is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Solas BioVentures
Check if Solas BioVentures has recently received funding, and reach out quickly before it becomes old news!
Click to see if Solas BioVentures had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Solas BioVentures has new funding data
Earning: See what the market has to say on Solas BioVentures recently announced quarterly report
Recommended Actions
Find VP level buyers at Solas BioVentures
Find 3 more new buyers
Compare Similar Companies to Solas BioVentures
Compare insights from companies similar to Solas BioVentures, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Solas BioVentures is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Solas BioVentures is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Solas BioVentures.
Solas BioVentures Tech Stack
A closer look at the technologies used by Solas BioVentures
Most Recent Scoops
Solas BioVentures News & Media
EirSystems Announces Close of Seed Financing Round to Advance Software for Preventing Prescription Abuse
CHATTANOOGA, Tenn.--(BUSINESS WIRE)--EirSystems, an emerging leader in software for e-prescriptions, closes seed funding round led by Solas Bioventures and Chain Reaction Boston.Vesalio Announces Oversubscribed Class A Financing
Vesalio, an emerging leader in improving outcomes in patients with vascular occlusion, is proud to announce it has oversubscribed its Class A financing round. Solas BioVentures led the investment with participation by new and existing investors, including the recent addition of Orlando Health Ventures. With an expanding customer base established in Europe, Vesalio will use this funding to enter the U.S. market by [PR.com]Pathware Closes $7 Million Series A Funding and Appoints MedTech Veteran as CEO
Pathware Inc., a MedTech company developing hardware and software to bring digital pathology from the central lab to the point-of-care, today announced it secured $7 million in an oversubscribed Series A financing. The funding will be used to continue expanding the team and to submit the system to the FDA for clearance. (PRWeb April 19, 2022) Read the full story at https://www.prweb.com/releases/2022/04/prweb18611661.htmVesalio Announces Appointment of Mike Kujak as Its New Independent Board Chairman
As an independent board chairman, Mike Kujak brings extensive medical start-up expertise. [PR.com]
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Solas BioVentures
Solas BioVentures is a venture capital firm based in Chattanooga, Tennessee, that specializes in early-stage investments in the life sciences sector, including biopharmaceuticals, medical devices, and digital health. The firm combines extensive expertise in medicine, biotechnology, operations, and finance, supported by a network of Limited Partners... Read More